Intracerebroventricular serotonin reduces the degree of acute hypoxic ventilatory depression in peripherally chemodenervated rabbits.
Hypoxia causes changes in the rate of synthesis or release of neurotransmitters in the brain. The accumulation of serotonin (5-HT) in the central nervous system might cause hypoxic respiratory depression. In the present study, we aimed to examine the role of central 5-HT on normoxic and acute hypoxic ventilatory depression (AHVD) in peripheral chemoreceptors denervated rabbits. All experiments were performed in peripherally chemodenervated rabbits anesthetized with intravenous injection of urethane (400 mg/kg) and alpha-chloralose (40 mg/kg). For intracerebroventricular (ICV) administration of 5-HT (20 microg/kg) and ketanserin (10 microg/kg), a cannula was placed in left lateral ventricle by stereotaxic method. Respiratory frequency (fR), tidal volume (VT), ventilation minute volume (VE) and systemic arterial bood pressure (BP) were recorded in each experimental phases and mean arterial pressure was calculated (MAP). Heart rate (HR) was also determined from the pulsation of BP. The effects of ICV serotonin and ICV ketanserin on the indicated parameters during air breathing (normoxia) and breathing of hypoxia (8% O2--92% N2) were investigated. During hypoxia, fR, VT, VE, MAP and HR decreased, and AHVD was thus obtained. ICV injection of 5-HT during normoxia caused significant increases in VT (P < 0.001) and in VE (P < 0.01). On the other hand, ICV 5-HT injection reduced the degree of AHVD in peripherally chemodenervated rabbits during hypoxia (fR; P < 0.05, VT; P < 0.05 and VE; P < 0.01). After ICV injection of ketanserin, the enhancement of 5-HT on VE was prevented during normoxia. On the breathing of hypoxic gas after ICV ketanserin, the degree of AHVD was augmented. In conclusion, our findings suggested that central 5-HT increases normoxic ventilation and reduces the degree of AHVD during hypoxia and that ICV ketanserin prevents the stimulatory effect of 5-HT on respiration and augments AHVD.
Guner
Ibrahim
I
Istanbul University, Cerrahpasa Faculty of Medicine, Department of Physiology, Istanbul, Turkey.
Sahin
Gulderen
G
Yelmen
Nermin Karaturan
NK
Aksu
Ugur
U
Oruc
Tulin
T
Yildirim
Zeynep
Z
D000208:Acute Disease; D000818:Animals; D002245:Carbon Dioxide / Q000378:metabolism; D002698:Chloralose; D006863:Hydrogen-Ion Concentration; D000860:Hypoxia / Q000503:physiopathology*; D007276:Injections, Intraventricular; D007650:Ketanserin / Q000494:pharmacology; D010100:Oxygen / Q000378:metabolism; D011817:Rabbits; D044263:Receptors, Serotonin, 5-HT1 / Q000187:drug effects; D044348:Receptors, Serotonin, 5-HT2 / Q000187:drug effects; D012119:Respiration / Q000187:drug effects*; D012131:Respiratory Insufficiency / Q000378:metabolism / Q000503:physiopathology* / Q000517:prevention & control*; D012701:Serotonin / Q000008:administration & dosage / Q000494:pharmacology*; D018490:Serotonin Agents / Q000008:administration & dosage / Q000494:pharmacology*; D012702:Serotonin Antagonists / Q000494:pharmacology; D013563:Sympathectomy, Chemical; D014520:Urethane
D044263:Receptors, Serotonin, 5-HT1; D044348:Receptors, Serotonin, 5-HT2; D018490:Serotonin Agents; D012702:Serotonin Antagonists; D002245:Carbon Dioxide; D002698:Chloralose; D012701:Serotonin; D014520:Urethane; D007650:Ketanserin; D010100:Oxygen